about
Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesienseDiscovery of Infection Associated Metabolic Markers in Human African TrypanosomiasisIdentification of a functional Antigen5-related allergen in the saliva of a blood feeding insect, the tsetse fly.Immunogenic salivary proteins of Triatoma infestans: development of a recombinant antigen for the detection of low-level infestation of triatomines.Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis.Central Nervous System Parasitosis and Neuroinflammation Ameliorated by Systemic IL-10 Administration in Trypanosoma brucei-Infected MiceSpatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma responseAntibody responses of domestic animals to salivary antigens of Triatomainfestans as biomarkers for low-level infestation of triatomines.Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile.The relationship of endotoxaemia to peripheral and central nervous system inflammatory responses in Human African Trypanosomiasis.A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence.Plasma neuronal specific enolase: a potential stage diagnostic marker in human African trypanosomiasis.Population genetics of Trypanosoma brucei rhodesiense: clonality and diversity within and between foci.Tsetse fly saliva biases the immune response to Th2 and induces anti-vector antibodies that are a useful tool for exposure assessment.Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients.Proinflammatory cytokine expression in the early phase of Trypanosoma brucei rhodesiense infection in vervet monkeys (Cercopithecus aethiops).IgM-antibody responses of chickens to salivary antigens of Triatoma infestans as early biomarkers for low-level infestation of triatomines.Trypanosoma brucei is protected from the cytostatic effects of nitric oxide under in vivo conditions.African trypanosomiasis: new insights for disease control. Preface.Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology.Suppressive macrophages occurring in murine Trypanosoma brucei infection inhibit T-cell responses in vivo and in vitro.Gene exchange in African trypanosomes: characterisation of a new hybrid genotype.African trypanosome infections in mice that lack the interferon-gamma receptor gene: nitric oxide-dependent and -independent suppression of T-cell proliferative responses and the development of anaemia.Immunobiology of African trypanosomiasisKinetoplastids: TrypanosomesCharacterization of the B-cell inhibitory protein factor in Ixodes ricinus tick saliva: a potential role in enhanced Borrelia burgdoferi transmissionIxodes ricinus tick salivary gland extract inhibits IL-10 secretion and CD69 expression by mitogen-stimulated murine splenocytes and induces hyporesponsiveness in B lymphocytesNitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite eliminationCharacterization of calcineurin from Hymenolepis microstoma and H. diminuta and its interaction with cyclosporin AHymenolepis diminuta and H. microstoma: uptake of cyclosporin A and drug binding to parasite cyclophilinsMolecular parasitology in ScotlandTrypanosoma brucei: Mammalian Epidermal Growth Factor Promotes the Growth of the African Trypanosome Bloodstream FormNitric oxide mediates suppression of T cell responses in murineTrypanosoma brucei infectionDot-blotting — a novel screening assay for antibodies in hybridoma cultures
P50
Q28476451-4145D77D-5AF4-421E-9648-CABBB204B250Q28550504-289976AD-ABF3-4B20-9AD3-8CC45B766D23Q33464446-C7E56574-DB40-4D54-93A0-7ECA47912B29Q33511445-2E467C0B-F30B-49DE-B76F-EF2D0EDC2273Q34474577-2E395DF6-386E-44CC-B412-CDB025CA5868Q34734108-CA25E54B-2105-4133-813C-EBACAE28B3C0Q35822797-D4FD8951-C121-48FC-95E4-9B880AAEDA53Q36152727-4EB336C9-61BD-4339-ADA2-F112A367BD92Q37357245-8F8D6A3E-6195-486C-80B9-97F79E5BD846Q37624109-2FAFAA1C-54E0-486A-B83F-C609927B1A72Q37724084-A9AB67DB-47B8-49DA-9626-DE048CE576EEQ37776021-D6EB25B1-600A-47BC-8832-385F5F6172D8Q38862534-F1610F18-B68B-4D51-9DF5-6D9048FD1E90Q38864029-2B61A5E6-9D1A-4F7F-834F-AE7277B687F1Q38879364-36422460-2F1F-4CB5-9046-915EC2D27E3EQ38880051-AA189725-851B-44CE-B187-B618BB89B99FQ40763872-8B72A050-BD9A-4460-B526-A22549E7305EQ44151555-C9E934F0-5031-4469-8C2D-23623FE98578Q46148476-44A824E8-F617-4529-B029-32C4617E6527Q46206821-9FAEF67D-CA02-4A52-91A5-4D73DCC11C73Q46226695-FC923586-EEEB-44DE-9B86-246701B50003Q46349086-9AA0999E-3973-4361-925B-74FCBF10F26EQ46607293-7C7EFCAE-6661-4AE2-ABDC-C0C7439FE430Q52532156-D5E998DD-3156-42DA-96E4-D24EBDF5661EQ58842889-95F9CDD0-3E9A-4A8F-A3B3-F704832C8D15Q58848713-62F63ED9-5100-4F76-AADF-4BE1FC3CA484Q58848726-411B9AC5-C8FB-42F8-8EA4-3D36067F1401Q58848733-785E4E2A-66C3-4D20-98D0-ECFBA9148A1FQ58848746-270CC1A5-5D09-465D-86BC-05768E81A4C8Q58848752-5BA6CD3B-2CC1-46C4-9D7F-D163978BD27FQ58848764-ED013F4E-BD6F-4CC8-8B86-807036170BFCQ58848772-6B48703E-9485-4D16-9505-E3CC543D91B5Q58848776-2A46CAE5-DBF0-4AC3-9306-00792D382254Q58848780-72940A19-AC53-4B44-A605-753D1AE66EACQ58848789-38DB1159-D241-4BB8-9E5F-A438FDCA4833
P50
description
researcher, ORCID id # 0000-0002-1596-3622
@en
wetenschapper
@nl
name
Jeremy M Sternberg
@ast
Jeremy M Sternberg
@en
Jeremy M Sternberg
@es
Jeremy M Sternberg
@nl
type
label
Jeremy M Sternberg
@ast
Jeremy M Sternberg
@en
Jeremy M Sternberg
@es
Jeremy M Sternberg
@nl
prefLabel
Jeremy M Sternberg
@ast
Jeremy M Sternberg
@en
Jeremy M Sternberg
@es
Jeremy M Sternberg
@nl
P106
P1153
7005055238
P21
P31
P496
0000-0002-1596-3622